# Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients

> **NCT04275024** · NA · COMPLETED · sponsor: **Guangdong Provincial Hospital of Traditional Chinese Medicine** · enrollment: 8 (actual)

## Conditions studied

- Mesenchymal Stromal Cells
- Psoriasis
- Drug Effect
- Drug Toxicity

## Interventions

- **DRUG:** Calcipotriol ointment
- **DRUG:** PSORI-CM01 Granule
- **BIOLOGICAL:** adipose-derived multipotent mesenchymal stem cells

## Key facts

- **NCT ID:** NCT04275024
- **Lead sponsor:** Guangdong Provincial Hospital of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-01
- **Primary completion:** 2020-06-17
- **Final completion:** 2021-02-03
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2023-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04275024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04275024, "Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04275024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*